Skip to main content
. 2020 Oct 23;10:578633. doi: 10.3389/fonc.2020.578633

Figure 1.

Figure 1

Trial flowchart shows participants selection and treatment diagram. Patients with a complete response discontinued TACE, whereas the other patients discontinued sorafenib. RFA, radiofrequency ablation; TACE, transarterial chemoembolization.